Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

NCT01336023 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1663

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/liraglutide
DRUG: insulin degludec
DRUG: liraglutide

Sponsor

Novo Nordisk A/S